 | • レポートコード：B-GIR09D3810 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、胆管がん治療薬の世界市場について調べ、まとめました。種類別セグメントは、5-フルオロウラシル（5-FU）、ゲムシタビン、シスプラチン、カペシタビン、オキサリプラチン、その他等、用途別セグメントは、病院・診療所、がん治療センター、その他等に区分しました。胆管がん治療薬の世界市場概観、企業動向、企業別胆管がん治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・胆管がん治療薬の市場概観 ・胆管がん治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・胆管がん治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・胆管がん治療薬の世界市場規模 ・胆管がん治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・胆管がん治療薬のアメリカ市場規模推移 ・胆管がん治療薬のカナダ市場規模推移 ・胆管がん治療薬のメキシコ市場規模推移 ・胆管がん治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・胆管がん治療薬のドイツ市場規模推移 ・胆管がん治療薬のイギリス市場規模推移 ・胆管がん治療薬のロシア市場規模推移 ・胆管がん治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・胆管がん治療薬の日本市場規模推移 ・胆管がん治療薬の中国市場規模推移 ・胆管がん治療薬の韓国市場規模推移 ・胆管がん治療薬のインド市場規模推移 ・胆管がん治療薬の東南アジア市場規模推移 ・胆管がん治療薬の南米市場分析（ブラジル、アルゼンチン等） ・胆管がん治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・胆管がん治療薬の種類別分析/販売量、売上、市場シェア（5-フルオロウラシル（5-FU）、ゲムシタビン、シスプラチン、カペシタビン、オキサリプラチン、その他） ・胆管がん治療薬の用途別分析/市場規模（病院・診療所、がん治療センター、その他） ・胆管がん治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・胆管がん治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unknown, but few factors that cause bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver fluke parasites leading to bile duct leading to cancer, and exposure to harmful chemicals or toxins. Major symptoms associated with bile duct cancer include jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. Some drugs used to treat bile duct cancer include 5-fluorouracil (5-fu), gemcitabine, cisplatin, capecitabine and oxaliplatin.
Scope of the Report:
The global Bile Duct Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bile Duct Cancer Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Bile Duct Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bile Duct Cancer Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Celgene
Mylan
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
Teva
AbbVie
Bristol-Myers Squibb
Pfizer
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
5-Fluorouracil (5-FU)
Gemcitabine
Cisplatin
Capecitabine
Oxaliplatin
Others
Market Segment by Applications, can be divided into
Hospitals & Clinic
Cancer Treatment Centers
Others
Table of Contents
1 Bile Duct Cancer Drugs Market Overview
1.1 Product Overview and Scope of Bile Duct Cancer Drugs
1.2 Classification of Bile Duct Cancer Drugs by Types
1.2.1 Global Bile Duct Cancer Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Bile Duct Cancer Drugs Revenue Market Share by Types in 2018
1.2.3 5-Fluorouracil (5-FU)
1.2.4 Gemcitabine
1.2.5 Cisplatin
1.2.6 Capecitabine
1.2.7 Oxaliplatin
1.2.8 Others
1.3 Global Bile Duct Cancer Drugs Market by Application
1.3.1 Global Bile Duct Cancer Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Bile Duct Cancer Drugs Market by Regions
1.4.1 Global Bile Duct Cancer Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Bile Duct Cancer Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bile Duct Cancer Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bile Duct Cancer Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Bile Duct Cancer Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bile Duct Cancer Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Bile Duct Cancer Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Business Overview
2.1.2 Bile Duct Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Celgene Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Bile Duct Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Bile Duct Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Bile Duct Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Accord Healthcare
2.5.1 Business Overview
2.5.2 Bile Duct Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Accord Healthcare Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Bile Duct Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Teva
2.7.1 Business Overview
2.7.2 Bile Duct Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 AbbVie
2.8.1 Business Overview
2.8.2 Bile Duct Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AbbVie Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Bile Duct Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Bile Duct Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.11 Intercept Pharmaceuticals
2.11.1 Business Overview
2.11.2 Bile Duct Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Intercept Pharmaceuticals Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.12 Novartis
2.12.1 Business Overview
2.12.2 Bile Duct Cancer Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novartis Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Bile Duct Cancer Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.14 Kyowa Hakko Kirin
2.14.1 Business Overview
2.14.2 Bile Duct Cancer Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Kyowa Hakko Kirin Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.15 Delcath Systems
2.15.1 Business Overview
2.15.2 Bile Duct Cancer Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Delcath Systems Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.16 Fresenius Kabi
2.16.1 Business Overview
2.16.2 Bile Duct Cancer Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Fresenius Kabi Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bile Duct Cancer Drugs Market Competition, by Players
3.1 Global Bile Duct Cancer Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Bile Duct Cancer Drugs Players Market Share
3.2.2 Top 10 Bile Duct Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 Global Bile Duct Cancer Drugs Market Size by Regions
4.1 Global Bile Duct Cancer Drugs Revenue and Market Share by Regions
4.2 North America Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
5 North America Bile Duct Cancer Drugs Revenue by Countries
5.1 North America Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
5.2 USA Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
6 Europe Bile Duct Cancer Drugs Revenue by Countries
6.1 Europe Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
6.2 Germany Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
6.4 France Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Bile Duct Cancer Drugs Revenue by Countries
7.1 Asia-Pacific Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
7.2 China Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
7.5 India Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
8 South America Bile Duct Cancer Drugs Revenue by Countries
8.1 South America Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
8.2 Brazil Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Bile Duct Cancer Drugs by Countries
9.1 Middle East and Africa Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
10 Global Bile Duct Cancer Drugs Market Segment by Type
10.1 Global Bile Duct Cancer Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Bile Duct Cancer Drugs Market Forecast by Type (2019-2024)
10.3 5-Fluorouracil (5-FU) Revenue Growth Rate (2014-2024)
10.4 Gemcitabine Revenue Growth Rate (2014-2024)
10.5 Cisplatin Revenue Growth Rate (2014-2024)
10.6 Capecitabine Revenue Growth Rate (2014-2024)
10.7 Oxaliplatin Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Bile Duct Cancer Drugs Market Segment by Application
11.1 Global Bile Duct Cancer Drugs Revenue Market Share by Application (2014-2019)
11.2 Bile Duct Cancer Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinic Revenue Growth (2014-2019)
11.4 Cancer Treatment Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Bile Duct Cancer Drugs Market Size Forecast (2019-2024)
12.1 Global Bile Duct Cancer Drugs Market Size Forecast (2019-2024)
12.2 Global Bile Duct Cancer Drugs Market Forecast by Regions (2019-2024)
12.3 North America Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
12.6 South America Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Bile Duct Cancer Drugs Picture
Table Product Specifications of Bile Duct Cancer Drugs
Table Global Bile Duct Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Bile Duct Cancer Drugs Revenue Market Share by Types in 2018
Figure 5-Fluorouracil (5-FU) Picture
Figure Gemcitabine Picture
Figure Cisplatin Picture
Figure Capecitabine Picture
Figure Oxaliplatin Picture
Figure Others Picture
Table Global Bile Duct Cancer Drugs Revenue (Million USD) by Application (2014-2024)
Figure Bile Duct Cancer Drugs Revenue Market Share by Applications in 2018
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Table Global Market Bile Duct Cancer Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Bile Duct Cancer Drugs Type and Applications
Table Celgene Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Bile Duct Cancer Drugs Type and Applications
Table Mylan Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Bile Duct Cancer Drugs Type and Applications
Table Eli Lilly Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Bile Duct Cancer Drugs Type and Applications
Table Johnson & Johnson Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table Accord Healthcare Bile Duct Cancer Drugs Type and Applications
Table Accord Healthcare Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Bile Duct Cancer Drugs Type and Applications
Table Roche Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Bile Duct Cancer Drugs Type and Applications
Table Teva Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Bile Duct Cancer Drugs Type and Applications
Table AbbVie Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Bile Duct Cancer Drugs Type and Applications
Table Bristol-Myers Squibb Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Bile Duct Cancer Drugs Type and Applications
Table Pfizer Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intercept Pharmaceuticals Bile Duct Cancer Drugs Type and Applications
Table Intercept Pharmaceuticals Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Bile Duct Cancer Drugs Type and Applications
Table Novartis Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Bile Duct Cancer Drugs Type and Applications
Table Sanofi Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Bile Duct Cancer Drugs Type and Applications
Table Kyowa Hakko Kirin Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Delcath Systems Basic Information, Manufacturing Base and Competitors
Table Delcath Systems Bile Duct Cancer Drugs Type and Applications
Table Delcath Systems Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius Kabi Bile Duct Cancer Drugs Type and Applications
Table Fresenius Kabi Bile Duct Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Bile Duct Cancer Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue Share by Players (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Share by Players in 2017
Figure Global Bile Duct Cancer Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Bile Duct Cancer Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Bile Duct Cancer Drugs Revenue Market Share in 2018
Figure Global Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Market Share by Regions in 2018
Figure North America Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South America Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table North America Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
Table North America Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Bile Duct Cancer Drugs Revenue Market Share by Countries in 2018
Figure USA Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Europe Bile Duct Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Bile Duct Cancer Drugs Revenue Market Share by Countries in 2018
Figure Germany Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UK Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure France Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Bile Duct Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Bile Duct Cancer Drugs Revenue Market Share by Countries in 2018
Figure China Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure India Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table South America Bile Duct Cancer Drugs Revenue by Countries (2014-2019)
Table South America Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Bile Duct Cancer Drugs Revenue Market Share by Countries in 2018
Figure Brazil Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Bile Duct Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bile Duct Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bile Duct Cancer Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Bile Duct Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Share by Type in 2019
Table Global Bile Duct Cancer Drugs Revenue Forecast by Type (2019-2024)
Figure Global Bile Duct Cancer Drugs Market Share Forecast by Type (2019-2024)
Figure Global 5-Fluorouracil (5-FU) Revenue Growth Rate (2014-2019)
Figure Global Gemcitabine Revenue Growth Rate (2014-2019)
Figure Global Cisplatin Revenue Growth Rate (2014-2019)
Figure Global Capecitabine Revenue Growth Rate (2014-2019)
Figure Global Oxaliplatin Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue by Application (2014-2019)
Table Global Bile Duct Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue Share by Application in 2019
Table Global Bile Duct Cancer Drugs Revenue Forecast by Application (2019-2024)
Figure Global Bile Duct Cancer Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospitals & Clinic Revenue Growth Rate (2014-2019)
Figure Global Cancer Treatment Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Bile Duct Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Bile Duct Cancer Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Bile Duct Cancer Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Europe Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
Figure South America Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Bile Duct Cancer Drugs Revenue Market Forecast (2019-2024)
世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…- 世界の腫瘍薬市場予測（～2024年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: Oncology Drugs is widely used For Blood Cancer, Bre…
- 世界の新がん診断市場予測（～2024年） Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation. Scope of the Report: The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …
- 世界のパーソナライズ癌医学市場予測（～2024年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…
- 世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…